JP2010532657A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010532657A5 JP2010532657A5 JP2010504730A JP2010504730A JP2010532657A5 JP 2010532657 A5 JP2010532657 A5 JP 2010532657A5 JP 2010504730 A JP2010504730 A JP 2010504730A JP 2010504730 A JP2010504730 A JP 2010504730A JP 2010532657 A5 JP2010532657 A5 JP 2010532657A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- antigen
- acid molecule
- fragment
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07107344 | 2007-05-02 | ||
| PCT/EP2008/055214 WO2008135446A2 (en) | 2007-05-02 | 2008-04-29 | Klebsiella antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010532657A JP2010532657A (ja) | 2010-10-14 |
| JP2010532657A5 true JP2010532657A5 (enExample) | 2011-07-14 |
Family
ID=39708006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010504730A Pending JP2010532657A (ja) | 2007-05-02 | 2008-04-29 | クレブシエラ属の抗原 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8236326B2 (enExample) |
| EP (5) | EP2497779A1 (enExample) |
| JP (1) | JP2010532657A (enExample) |
| CN (1) | CN102015754A (enExample) |
| AU (1) | AU2008248755A1 (enExample) |
| CA (1) | CA2685805A1 (enExample) |
| WO (1) | WO2008135446A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008248755A1 (en) * | 2007-05-02 | 2008-11-13 | Intercell Ag | Klebsiella antigens |
| US9150621B2 (en) * | 2008-08-28 | 2015-10-06 | The University Of Queensland | Mutant bacterial glycoproteins and uses thereof |
| US9169477B2 (en) | 2012-01-27 | 2015-10-27 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for immunization against bacteria expressing a carbapenemase |
| KR101605846B1 (ko) * | 2013-11-20 | 2016-03-23 | 한국과학기술연구원 | 클렙시엘라 뉴모니아에 특이적으로 결합하는 단일가닥 핵산 앱타머 및 이를 이용한 클렙시엘라 뉴모니아 검출 방법 |
| WO2016113252A2 (en) | 2015-01-12 | 2016-07-21 | Evaxion Biotech Aps | Proteins and nucleic acids useful in vaccines targeting klebsiella pneumoniae |
| CN107921114A (zh) | 2015-07-10 | 2018-04-17 | 埃皮托皮克斯有限责任公司 | 包含克雷伯氏菌属蛋白的蛋白质和免疫组合物以及使用方法 |
| WO2017035154A1 (en) * | 2015-08-24 | 2017-03-02 | Medimmune, Llc | Mrka polypeptides, antibodies, and uses thereof |
| CN108699137A (zh) * | 2015-10-28 | 2018-10-23 | 阿尔萨尼斯生物科学有限责任公司 | 靶向基于甘露聚糖的肺炎克雷伯氏菌的o-抗原的抗体 |
| US11447542B2 (en) | 2016-08-05 | 2022-09-20 | Medimmune, Llc | Anti-O2 antibodies and uses thereof |
| US10759848B2 (en) | 2016-08-12 | 2020-09-01 | Arsanis Biosciences Gmbh | Klebsiella pneumoniae O3 specific antibodies |
| WO2018075375A1 (en) | 2016-10-19 | 2018-04-26 | Medimmune, Llc | Anti-o1 antibodies and uses thereof |
| CN110540600B (zh) * | 2018-12-20 | 2021-01-29 | 湖北工业大学 | 基于肺炎克雷伯菌表面蛋白的乳胶微球免疫层析试纸的制备方法 |
| CN110540599B (zh) * | 2018-12-20 | 2021-04-06 | 湖北工业大学 | 基于肺炎克雷伯菌表面蛋白抗体的肺炎克雷伯菌Elisa检测试剂盒及制备方法 |
| CN110540595B (zh) * | 2018-12-20 | 2021-04-06 | 湖北工业大学 | 一种肺炎克雷伯菌抗体乳胶微球免疫层析检测试纸的制备方法 |
| CN111150839A (zh) * | 2019-12-17 | 2020-05-15 | 中国科学院深圳先进技术研究院 | 一种用于免疫接种的组合物及其制备方法 |
| CN112505324A (zh) * | 2020-11-06 | 2021-03-16 | 杭州迅耀生物科技有限公司 | 一种新型冠状病毒检测方法 |
| CN120775040A (zh) * | 2021-08-25 | 2025-10-14 | 北京三诺佳邑生物技术有限责任公司 | 特异性识别肺炎克雷伯菌o1抗原的抗体及其应用 |
| CN115838431A (zh) * | 2022-07-08 | 2023-03-24 | 中国人民解放军陆军军医大学 | 一种用作肺炎克雷伯菌疫苗抗原的融合蛋白KP-Ag2及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| ES2251009T3 (es) | 1990-06-28 | 2006-04-16 | Sanofi-Aventis Deutschland Gmbh | Proteinas de fusion con partes de inmunoglobulinas, su preparacion y uso. |
| EP1167378B1 (en) | 1994-07-15 | 2011-05-11 | University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| CO4600681A1 (es) | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
| US6605713B1 (en) * | 1996-08-30 | 2003-08-12 | Jens Peter Furste | Mirror-symmetrical selection and evolution of nucleic acids |
| US5849902A (en) | 1996-09-26 | 1998-12-15 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| US5989912A (en) | 1996-11-21 | 1999-11-23 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| DE19803453A1 (de) | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
| US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| DE60130877T2 (de) | 2000-04-14 | 2008-07-17 | Intercell Ag | Modifizierte peptide enthaltende pharmazeutische präparationen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| JP5271471B2 (ja) | 2000-06-08 | 2013-08-21 | インターツェル・アクチェンゲゼルシャフト | 免疫促進性オリゴデオキシヌクレオチド |
| CA2418854A1 (en) | 2000-08-17 | 2002-02-21 | Jorg Fritz | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| CN1526016A (zh) | 2001-05-21 | 2004-09-01 | �����ɷ� | 稳定核酸的方法 |
| JP2005519035A (ja) | 2001-12-07 | 2005-06-30 | インターツェル・アクチェンゲゼルシャフト | 免疫促進性オリゴデオキシヌクレオチド |
| US20070128183A1 (en) * | 2004-04-27 | 2007-06-07 | Intercell Ag | Td antigens |
| AU2008248755A1 (en) * | 2007-05-02 | 2008-11-13 | Intercell Ag | Klebsiella antigens |
| DE102012005675A1 (de) | 2012-03-21 | 2013-09-26 | Daimler Ag | Kraftfahrzeugantriebsstrangvorrichtung mit einem Mehrgruppengetriebe |
-
2008
- 2008-04-29 AU AU2008248755A patent/AU2008248755A1/en not_active Abandoned
- 2008-04-29 JP JP2010504730A patent/JP2010532657A/ja active Pending
- 2008-04-29 EP EP12160355A patent/EP2497779A1/en not_active Withdrawn
- 2008-04-29 EP EP12160364A patent/EP2489673A3/en not_active Withdrawn
- 2008-04-29 US US12/598,176 patent/US8236326B2/en not_active Expired - Fee Related
- 2008-04-29 CN CN2008800222372A patent/CN102015754A/zh active Pending
- 2008-04-29 EP EP10010874A patent/EP2360177A1/en not_active Withdrawn
- 2008-04-29 EP EP08736618A patent/EP2152731A2/en not_active Ceased
- 2008-04-29 EP EP10010873A patent/EP2338902A1/en not_active Withdrawn
- 2008-04-29 WO PCT/EP2008/055214 patent/WO2008135446A2/en not_active Ceased
- 2008-04-29 CA CA002685805A patent/CA2685805A1/en not_active Abandoned
-
2012
- 2012-07-06 US US13/543,049 patent/US8637052B2/en not_active Expired - Fee Related
-
2013
- 2013-12-11 US US14/102,775 patent/US20140212448A1/en not_active Abandoned